Pharmacophore modeling, virtual screening, molecular docking and dynamics studies for the discovery of HER2-tyrosine kinase inhibitors: An in-silico approach
Authors:
- Gurubasavaraja Swamy Purwarga MatadaGMGurubasavaraja Swamy Purwarga Matada
- Prasad Sanjay DhiwarPDPrasad Sanjay Dhiwar
- Nahid AbbasNANahid Abbas
- Ekta SinghESEkta Singh
- Abhishek GharaAGAbhishek Ghara
- Rajesh PatilRPRajesh Patil
- Nulgumnalli Manjunathaiah RaghavendraNRNulgumnalli Manjunathaiah Raghavendra
- 5 February 2022
- journal article
- research article
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1257
Abstract
No abstract availableKeywords
Funding Information
- Indian Council of Medical Research
This publication has 72 references indexed in Scilit:
- Structural Analysis of the Mechanism of Inhibition and Allosteric Activation of the Kinase Domain of HER2 ProteinJournal of Biological Chemistry, 2011
- Quantitative Prediction of Fold Resistance for Inhibitors of EGFRBiochemistry, 2009
- CHARMM general force field: A force field for drug‐like molecules compatible with the CHARMM all‐atom additive biological force fieldsJournal of Computational Chemistry, 2009
- Structures of Lung Cancer-Derived EGFR Mutants and Inhibitor Complexes: Mechanism of Activation and Insights into Differential Inhibitor SensitivityCancer Cell, 2007
- Canonical sampling through velocity rescalingThe Journal of Chemical Physics, 2007
- EGF–ERBB signalling: towards the systems levelNature Reviews Molecular Cell Biology, 2006
- An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor ReceptorCell, 2006
- ERBB receptors and cancer: the complexity of targeted inhibitorsNature Reviews Cancer, 2005
- Electrostatics of nanosystems: Application to microtubules and the ribosomeProceedings of the National Academy of Sciences, 2001
- Molecular dynamics with coupling to an external bathThe Journal of Chemical Physics, 1984